FICO, Tempus AI, Tenable Price Targets, October 26 2026
FICO
FICO, formally Fair Isaac, sells the FICO Score that most US lenders use to judge credit risk. Its Scores segment licenses those scores to lenders and credit bureaus. Its Software segment sells decision and analytics tools to banks. The company is based in Bozeman, Montana. Fiscal third-quarter revenue came to $674.2 million, 0.3% below the $676.44 million consensus. Earnings were $12.18 a share, 4.1% above the $11.70 expected. FICO put the gain down to a higher price per mortgage score. B2B scores revenue was 49% higher than a year earlier. Software revenue grew 2%.
FICO said it will hold its wholesale mortgage price at $10 for lenders and brokers in its Preferred Program. The bundle covers both the Classic FICO Score and FICO Score 10T. The 10T version adds trended credit data and rent payment history, which the classic score leaves out. Chief executive Will Lansing said the flat price gives lenders “the trusted and predictive tools they need.” FICO reports its fiscal fourth quarter on November 4. The consensus there is $10.86 a share on $658.1 million in revenue.
Wells Fargo Downgrades FICO
Jason Haas of Wells Fargo downgraded FICO to Equal Weight from Overweight and cut the price target from $800 to $735 today, a Monday. Summaries of the note say he expects the Preferred Program to keep lenders on FICO. He also sees it capping earnings upside. Ryan Griffin of BMO Capital maintained FICO at Outperform and lowered the price target from $1,150 to $897. Alexander Hess of JPMorgan maintained FICO at Neutral and lowered the price target from $1,530 to $900. Kevin McVeigh of UBS maintained FICO at Neutral and lowered the price target from $1,100 to $942.
The month had already brought a run of cuts. Sean Kennedy of Mizuho kept Outperform and cut the price target from $1,344 to $1,063 on October 19. Ashish Sabadra of RBC Capital kept Outperform and lowered the price target from $1,525 to $1,045 on October 16. Patrick O’Shaughnessy of Raymond James kept Outperform and cut the price target from $1,750 to $1,230 on October 13. Kyle Peterson of Needham kept Buy and lowered the price target from $1,650 to $1,100 the same day.
FICO’s Record on AnaChart
FICO draws 14 covering analysts on AnaChart. Their average target is $1,465.12, a figure that predates most of October’s cuts. The high is $2,400 and the low is $700. Ratings split 82.22% Buy and 17.78% Hold. AnaChart’s tracking shows 59.01% of FICO targets get met, after about 85 days on average. Haas has met 2 of his 13 targets on the stock, with an average potential upside of 16.01%. Manav Patnaik of Barclays has met 25 of 33, with an average potential upside of 32.33%.
Tempus AI
Tempus AI runs genomic tests for cancer patients. It sells the clinical data it gathers to drug makers. It uses AI tools to sort that data and match patients to trials. Its tests include the xT solid tumor panel. The company is based in Chicago. Second-quarter revenue came to $382.5 million. The loss was $0.04 a share, half the $0.08 loss expected. Tempus guided 2026 revenue to $1.59 billion to $1.6 billion. That is in line with the $1.59 billion consensus.
On Friday, Pathos AI announced multi-year collaborations with Bristol Myers Squibb and Tempus. The work will build a curated dataset and AI tools for Alzheimer’s disease and other neurological conditions. Tempus reports its third quarter on November 2, with a consensus of $0.01 a share.
Two Desks Back Tempus AI
Yi Chen of HC Wainwright kept Buy and raised the price target from $66 to $68 today, a Monday. Mark Massaro of BTIG reiterated Buy with an $80 price target.
Tempus AI’s Record on AnaChart
Tempus AI draws 15 covering analysts on AnaChart. Their average target is $72.87, with a high of $95 and a low of $50. Ratings split 64.44% Buy and 35.56% Hold. AnaChart’s tracking shows 80.51% of Tempus AI targets get met, after about 48 days on average. Chen has met 5 of his 7 targets on the stock, with an average potential upside of 11.85%. Ryan MacDonald of Needham has met 12 of 13, with an average potential upside of 10.91%.
Tenable
Tenable sells exposure management software. It finds and ranks security weak spots across a company’s networks, cloud and devices. Its products include Nessus and the Tenable One platform. It is based in Columbia, Maryland. Second-quarter revenue came to $268.5 million, 1.4% above the $264.87 million consensus. It also topped the $263 million to $266 million range Tenable had guided in April. Earnings were $0.51 a share, 8.5% above the $0.47 expected. Tenable then guided full-year revenue to $1.075 billion to $1.081 billion, against a $1.074 billion consensus.
Tenable reports its third quarter on Wednesday, October 28. The consensus there is $0.51 a share on $271.58 million in revenue. Earlier this month the company closed a new $400 million secured credit facility.
Baird Raises Its Tenable Target
Shrenik Kothari of Baird kept Outperform and raised the price target from $41 to $50 today, a Monday. Jonathan Ruykhaver of Cantor Fitzgerald reiterated Overweight with a $45 price target.
Two desks had raised the week before. Junaid Siddiqui of Truist kept Hold and raised the price target from $30 to $35 on October 20. Richard Poland of Wells Fargo kept Hold and lifted the price target from $35 to $38 on October 15.
Tenable’s Record on AnaChart
Tenable draws 18 covering analysts on AnaChart. Their average target is $33.16, with a high of $50 and a low of $22. Ratings split 47.54% Buy and 52.46% Hold. AnaChart’s tracking shows 56.67% of Tenable targets get met, after about 161 days on average. Adam Borg of Stifel has met 7 of his 8 targets on the stock, with an average potential upside of negative 4.76%. Poland has met 3 of 4, with an average potential upside of negative 3.36%.
What the Performance Matrix Shows
Tempus AI has the best met ratio of the three, and Tenable the lowest. A Tempus AI target that gets met lands in about 48 days. AnaChart’s first FICO forecast dates to December 2010. Its first Tenable forecast dates to August 2018, and its first Tempus AI forecast to July 2024.
AnaChart tracks every price target against what happened to the stock afterward, desk by desk and analyst by analyst. The ticker pages linked above break out each record by analyst, firm and year. AnaChart’s full data set holds more than 760,000 analyst calls on more than 9,000 tickers, active and delisted. More than 680,000 carry a price target and more than 730,000 carry a rating. It is the second largest database of its kind. The raw file is available through the AnaChart store.
The previous update covered Western Digital, RingCentral and Deckers on October 23.
